Throwing Velocity and Patient Reported Outcomes in Elite Level Handball Players After Completion … (NCT06459258) | Clinical Trial Compass
CompletedNot Applicable
Throwing Velocity and Patient Reported Outcomes in Elite Level Handball Players After Completion of Shoulder-Pacemaker Strength Training
Austria14 participantsStarted 2023-03-01
Plain-language summary
The successful application of treatment protocols using motion-triggered neuromuscular electrical stimulation (NMES) for treatment-resistant functional posterior shoulder instability was recently demonstrated. The purpose of this study is to evaluate the concept of a motion-triggered NMES training protocol through objective clinical outcome parameters and its impact on external rotational (ER) shoulder strength and throwing velocity in healthy, elite-level handball players.
Who can participate
Age range
18 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Elite level handball players healthy and actively competing at the time of the study
* Patients must be at least 18 years at the time of signing the informed consent
* Pregnancy must be ruled out in the case of female participants (e.g., pregnancy test)
* Patient must be available for all specified assessments throughout the study duration
* All patients are required to give written informed consent before enrollment
Exclusion Criteria:
* age \<18,
* history of type I or II shoulder instability according to the Stanmore classification12,
* existing pain syndrome (defined by pain at rest or during motion that is not caused by dislocation and impedes training),
* recent shoulder surgery (\<1 year).
* Contraindication to SPM treatment (e.g., cardiac pacemaker)
* Neurological disorders or nerve injuries causing the instability
* Uncontrolled alcohol or substance abuse
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Throwing velocity (km*h-1)
Timeframe: Baseline to 6-week post-intervention follow-up.